HBIO Stock Analysis: Buy, Sell, or Hold?
HBIO - Harvard Bioscience Inc
$6.10
0.01 (0.16%)
▲
5d:
+1.67%
30d:
+0.83%
90d:
-4.39%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 11, 2026
8d
Get Alerted When HBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HBIO shows positive signals but monitor for confirmation. Market pricing in 14.8% growth. Moderate conviction.
💡 BUY OPPORTUNITY: HBIO shows positive signals but monitor for confirmation. Market pricing in 14.8% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.67
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$3.52
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HBIO is currently trading at $6.10, which is considered fair relative to its 30-day fair value range of $5.97 to $6.26. From a valuation perspective, the stock is trading at a premium (Forward PE: 13.9) compared to its historical average (9.2). At these levels, the market is pricing in 14.8% annual earnings growth.
Technical Outlook: Technically, HBIO is in a uptrend. The price is approaching resistance at $6.28. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HBIO is in a uptrend. The price is approaching resistance at $6.28. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$5.97 -
$6.26
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($6.00)
- BULLISH: Expecting earnings turnaround to 14.8% growth with -4.7% revenue growth
Trading Range Analysis
30-Day Trading Range
$5.97 -
$6.26
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$5.91
Resistance Level
$6.28
Current Trend
Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.86
Wall Street Target
$6.00
(-1.6%)
Revenue Growth (YoY)
-4.7%
Earnings Growth (YoY)
-80.3%
Profit Margin
-11.4%
Valuation Premium vs History
+14.8% premium
PE vs Historical
13.9 vs 9.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+14.8%
(market-implied from PE analysis)
1-Year Target
$7.00
(+15%)
2-Year Target
$8.04
(+32%)
3-Year Target
$9.23
(+51%)
3-Yr Target (if PE normalizes)
(PE: 14→9)
PE COMPRESSION
$6.12
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: August 02, 2026 12:49 PM ET
Data refreshes hourly during market hours. Next update: 1:49 PM
Data refreshes hourly during market hours. Next update: 1:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HBIO showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Stephen J Denelsky
BUY
10000 shares
2026-03-17
William Snider
BUY
8475 shares
2026-03-17
John D Duke
BUY
5000 shares
2026-03-16
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$477 | 47 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$87 | 50 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 50 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 56 HOLD |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$15 | 56 HOLD |
